Literature DB >> 17352933

Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease.

Damian M Cummings1, Austen J Milnerwood, Glenn M Dallérac, Sarat C Vatsavayai, Mark C Hirst, Kerry P S J Murphy.   

Abstract

Huntington's disease is a fatal neurodegenerative disorder characterised by a progressive motor, psychiatric and cognitive decline and associated with a marked loss of neurons in the cortex and striatum of affected individuals. The disease is inherited in an autosomal dominant fashion and is caused by a trinucleotide (CAG) repeat expansion in the gene encoding the protein huntingtin. Predictive genetic testing has revealed early cognitive deficits in asymptomatic gene carriers such as altered working memory, executive function and recognition memory. The perirhinal cortex is believed to process aspects of recognition memory. Evidence from primate studies suggests that decrements in neuronal firing within this cortical region encode recognition memory and that the underlying mechanism is an activity-dependent long-term depression (LTD) of excitatory neurotransmission, the converse of long-term potentiation (LTP). We have used the R6/1 mouse model of HD to assess synaptic plasticity in the perirhinal cortex. This mouse model provides an ideal tool for investigating early and progressive changes in synaptic function in HD. We report here that LTD at perirhinal synapses is markedly reduced in R6/1 mice. We also provide evidence to suggest that a reduction in dopamine D2 receptor signalling may be implicated.

Entities:  

Mesh:

Year:  2006        PMID: 17352933     DOI: 10.1016/j.brainresbull.2006.10.016

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

Review 1.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

2.  Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease.

Authors:  Sebastien Cayzac; Sebastien Delcasso; Vietminh Paz; Yannick Jeantet; Yoon H Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

3.  Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.

Authors:  Tim Indersmitten; Conny H Tran; Carlos Cepeda; Michael S Levine
Journal:  J Neurophysiol       Date:  2015-02-11       Impact factor: 2.714

4.  Altered information processing in the prefrontal cortex of Huntington's disease mouse models.

Authors:  Adam G Walker; Benjamin R Miller; Jenna N Fritsch; Scott J Barton; George V Rebec
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

5.  Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington's disease.

Authors:  Ferah Yildirim; Christopher W Ng; Vincent Kappes; Tobias Ehrenberger; Siobhan K Rigby; Victoria Stivanello; Theresa A Gipson; Anthony R Soltis; Peter Vanhoutte; Jocelyne Caboche; David E Housman; Ernest Fraenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-19       Impact factor: 11.205

6.  Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load.

Authors:  Austen J Milnerwood; Lynn A Raymond
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

Review 7.  Role of cerebral cortex in the neuropathology of Huntington's disease.

Authors:  Ana M Estrada-Sánchez; George V Rebec
Journal:  Front Neural Circuits       Date:  2013-02-18       Impact factor: 3.492

8.  Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts.

Authors:  Fiorella Malchiodi-Albedi; Silvia Paradisi; Andrea Matteucci; Claudio Frank; Marco Diociaiuti
Journal:  Int J Alzheimers Dis       Date:  2011-02-08

9.  Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease.

Authors:  Benjamin R Miller; Adam G Walker; Scott J Barton; George V Rebec
Journal:  Front Syst Neurosci       Date:  2011-05-09

Review 10.  Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies.

Authors:  Francisco J Carvajal; Hayley A Mattison; Waldo Cerpa
Journal:  Neural Plast       Date:  2016-08-18       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.